| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | PCDHA9 SPTA1 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 LRP1B EPS15L1 CDH22 EEF2K EDEM1 ATP2A2 LTBP4 | 8.10e-07 | 749 | 99 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.01e-04 | 49 | 99 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 1.45e-04 | 4 | 99 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.10e-04 | 109 | 99 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.54e-04 | 28 | 99 | 3 | GO:0140326 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 2.93e-07 | 187 | 99 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 ELFN1 | 2.65e-06 | 313 | 99 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 6.82e-05 | 3 | 99 | 2 | GO:0021627 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.70e-04 | 451 | 98 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.06e-04 | 477 | 98 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.95e-04 | 503 | 98 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | spectrin | 7.67e-04 | 9 | 98 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 7.85e-04 | 523 | 98 | 9 | GO:0098984 | |
| Domain | Cadherin_tail | 1.46e-11 | 37 | 98 | 8 | PF15974 | |
| Domain | Cadherin_CBD | 1.46e-11 | 37 | 98 | 8 | IPR031904 | |
| Domain | Cadherin_2 | 1.70e-09 | 65 | 98 | 8 | PF08266 | |
| Domain | Cadherin_N | 1.70e-09 | 65 | 98 | 8 | IPR013164 | |
| Domain | Cadherin_CS | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 5.74e-09 | 109 | 98 | 9 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 7.90e-09 | 113 | 98 | 9 | PS00232 |
| Domain | Cadherin | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 7.90e-09 | 113 | 98 | 9 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 8.54e-09 | 114 | 98 | 9 | PS50268 |
| Domain | - | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 8.54e-09 | 114 | 98 | 9 | 2.60.40.60 |
| Domain | CA | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 9.22e-09 | 115 | 98 | 9 | SM00112 |
| Domain | Cadherin-like | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 9.96e-09 | 116 | 98 | 9 | IPR015919 |
| Domain | Cadherin | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CDH22 | 1.16e-08 | 118 | 98 | 9 | IPR002126 |
| Domain | ABC_A | 3.42e-07 | 12 | 98 | 4 | IPR026082 | |
| Domain | AAA | 1.08e-05 | 144 | 98 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.08e-05 | 144 | 98 | 7 | IPR003593 | |
| Domain | ABC_tran | 1.16e-04 | 48 | 98 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.16e-04 | 48 | 98 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.26e-04 | 49 | 98 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.36e-04 | 50 | 98 | 4 | IPR003439 | |
| Domain | Spectrin | 2.30e-04 | 23 | 98 | 3 | PF00435 | |
| Domain | CH | 3.78e-04 | 65 | 98 | 4 | SM00033 | |
| Domain | Spectrin_repeat | 4.64e-04 | 29 | 98 | 3 | IPR002017 | |
| Domain | CH | 5.01e-04 | 70 | 98 | 4 | PF00307 | |
| Domain | - | 5.29e-04 | 71 | 98 | 4 | 1.10.418.10 | |
| Domain | CH | 5.88e-04 | 73 | 98 | 4 | PS50021 | |
| Domain | SPEC | 6.22e-04 | 32 | 98 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.22e-04 | 32 | 98 | 3 | IPR018159 | |
| Domain | CH-domain | 6.51e-04 | 75 | 98 | 4 | IPR001715 | |
| Domain | ABC_transporter_CS | 1.39e-03 | 42 | 98 | 3 | IPR017871 | |
| Domain | PUA-like_domain | 4.40e-03 | 19 | 98 | 2 | IPR015947 | |
| Pubmed | 2.62e-17 | 15 | 102 | 8 | 15640798 | ||
| Pubmed | 9.83e-17 | 17 | 102 | 8 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.77e-16 | 18 | 102 | 8 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.77e-16 | 18 | 102 | 8 | 10662547 | |
| Pubmed | 2.93e-15 | 24 | 102 | 8 | 24698270 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.22e-14 | 28 | 102 | 8 | 15347688 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.50e-13 | 11 | 102 | 6 | 9655502 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 6.07e-12 | 57 | 102 | 8 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 7.03e-12 | 58 | 102 | 8 | 30377227 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.65e-11 | 68 | 102 | 8 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 4.24e-11 | 72 | 102 | 8 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 5.32e-11 | 74 | 102 | 8 | 10817752 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 5.94e-11 | 75 | 102 | 8 | 15372022 | |
| Pubmed | 7.37e-11 | 77 | 102 | 8 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.01e-10 | 80 | 102 | 8 | 10716726 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 1.53e-10 | 12 | 102 | 5 | 10612399 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 2.48e-09 | 119 | 102 | 8 | 28625976 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 SNX29 | 6.08e-09 | 193 | 102 | 9 | 22589738 | |
| Pubmed | USP34 ABCA2 ZNF423 APC AIP EXTL3 RFX5 LRP1B EPS15L1 ATRNL1 NAV3 ZNF76 USP54 ATP2A2 MED13 CAP2 | 1.05e-06 | 1285 | 102 | 16 | 35914814 | |
| Pubmed | WSB1 AEN SPOUT1 INTS1 RPS15A PCDHA13 HEATR1 SLC6A9 EIF2D PIK3R2 XRN1 SLTM ANKRD17 MAPK6 MED13 LCMT1 | 1.59e-06 | 1327 | 102 | 16 | 32694731 | |
| Pubmed | 3.71e-06 | 529 | 102 | 10 | 14621295 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 USP34 RANBP10 ABCA2 SPOUT1 BCAS3 INTS1 EXTL3 ATG2A PCNX2 EPS15L1 MROH1 LTBP4 MED13 | 4.35e-06 | 1105 | 102 | 14 | 35748872 |
| Pubmed | 5.97e-06 | 329 | 102 | 8 | 17474147 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29766838 | ||
| Pubmed | ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. | 8.52e-06 | 2 | 102 | 2 | 15649702 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25338755 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 1282354 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10970803 | ||
| Pubmed | Cloning of two novel ABC transporters mapping on human chromosome 9. | 8.52e-06 | 2 | 102 | 2 | 8088782 | |
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 8.52e-06 | 2 | 102 | 2 | 14697259 | |
| Pubmed | 1.94e-05 | 18 | 102 | 3 | 25220460 | ||
| Pubmed | NOX4 inhibition promotes the remodeling of dystrophic muscle. | 2.55e-05 | 3 | 102 | 2 | 36278481 | |
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 2.55e-05 | 3 | 102 | 2 | 29477871 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24097981 | ||
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.80e-05 | 59 | 102 | 4 | 23754746 | |
| Pubmed | RPS15A APC DHX15 GRIP1 EPS15L1 XRN1 ANKRD17 NUMB ATP2A2 EPB41L1 | 4.54e-05 | 708 | 102 | 10 | 39231216 | |
| Pubmed | Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K. | 5.09e-05 | 4 | 102 | 2 | 34895463 | |
| Pubmed | Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury. | 5.09e-05 | 4 | 102 | 2 | 29065150 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18455124 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 31411676 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26849305 | ||
| Pubmed | UACA RPS15A APC ZC3H6 DIS3 DHX15 EIF2D SMPDL3B PIK3R2 XRN1 ANKRD17 ATP2A2 MED13 | 7.38e-05 | 1247 | 102 | 13 | 27684187 | |
| Pubmed | 7.60e-05 | 347 | 102 | 7 | 17114649 | ||
| Pubmed | USP34 AEN SPOUT1 APC HEATR1 DIS3 GRSF1 ATRNL1 PRAMEF14 RNASEH2C SLTM ANKRD17 | 8.12e-05 | 1084 | 102 | 12 | 11544199 | |
| Pubmed | Addition of poly(A) and poly(A)-rich tails during RNA degradation in the cytoplasm of human cells. | 8.47e-05 | 5 | 102 | 2 | 20368444 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 34888534 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 27148972 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 20656885 | ||
| Pubmed | 9.55e-05 | 486 | 102 | 8 | 20936779 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.01e-04 | 363 | 102 | 7 | 14691545 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 1.12e-04 | 84 | 102 | 4 | 15203218 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.13e-04 | 498 | 102 | 8 | 36634849 | |
| Pubmed | 1.14e-04 | 32 | 102 | 3 | 23049088 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 7568168 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 30463013 | ||
| Pubmed | NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. | 1.27e-04 | 6 | 102 | 2 | 24743017 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 23756462 | ||
| Pubmed | Juxtaposition of CNR protocadherins and reelin expression in the developing spinal cord. | 1.27e-04 | 6 | 102 | 2 | 11312598 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 31746486 | ||
| Pubmed | 1.29e-04 | 650 | 102 | 9 | 38777146 | ||
| Pubmed | 1.33e-04 | 653 | 102 | 9 | 22586326 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.47e-04 | 90 | 102 | 4 | 35654790 | |
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 7766993 | ||
| Pubmed | DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. | 1.77e-04 | 7 | 102 | 2 | 9286858 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 2.09e-04 | 853 | 102 | 10 | 28718761 | |
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 24293640 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 2.63e-04 | 564 | 102 | 8 | 21565611 | |
| Pubmed | 2.66e-04 | 105 | 102 | 4 | 9628581 | ||
| Pubmed | 2.83e-04 | 430 | 102 | 7 | 32581705 | ||
| Pubmed | 2.85e-04 | 107 | 102 | 4 | 30995489 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.86e-04 | 724 | 102 | 9 | 36232890 | |
| Pubmed | Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. | 3.03e-04 | 9 | 102 | 2 | 11162594 | |
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 9303539 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 34489457 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 37149635 | ||
| Pubmed | Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. | 3.77e-04 | 10 | 102 | 2 | 18423202 | |
| Pubmed | 4.60e-04 | 11 | 102 | 2 | 19146812 | ||
| Pubmed | 4.88e-04 | 52 | 102 | 3 | 9455477 | ||
| Pubmed | Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. | 5.16e-04 | 53 | 102 | 3 | 7774911 | |
| Pubmed | 5.42e-04 | 225 | 102 | 5 | 12168954 | ||
| Pubmed | 5.53e-04 | 226 | 102 | 5 | 31452512 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 5.91e-04 | 974 | 102 | 10 | 28675297 | |
| Pubmed | 5.97e-04 | 130 | 102 | 4 | 12421765 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SPOUT1 RPS15A HEATR1 DIS3 GRSF1 DHX15 EIF2D XRN1 SLTM ANKRD17 TP53RK ATP2A2 | 6.13e-04 | 1353 | 102 | 12 | 29467282 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.25e-04 | 807 | 102 | 9 | 22681889 | |
| Pubmed | 6.62e-04 | 496 | 102 | 7 | 31343991 | ||
| Pubmed | 7.53e-04 | 242 | 102 | 5 | 34011540 | ||
| Pubmed | 7.57e-04 | 14 | 102 | 2 | 15082773 | ||
| Pubmed | Structural and functional insights into the B30.2/SPRY domain. | 7.57e-04 | 14 | 102 | 2 | 16498413 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PLXNA3 USP34 ABCA2 RNF213 AIP EXTL3 LRP1B DHX15 OAF EDEM1 ATP2A2 | 8.05e-04 | 1201 | 102 | 11 | 35696571 |
| Pubmed | Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity. | 8.72e-04 | 15 | 102 | 2 | 26880306 | |
| Pubmed | 8.72e-04 | 15 | 102 | 2 | 23218918 | ||
| Pubmed | 8.72e-04 | 15 | 102 | 2 | 31903119 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.68e-04 | 256 | 102 | 5 | 33397691 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 9.68e-04 | 256 | 102 | 5 | 24189400 | |
| Pubmed | BCAS3 SPTA1 RPS15A APC GRIN2A DHX15 EPS15L1 XRN1 USP54 DMD ATP2A2 EPB41L1 | 9.97e-04 | 1431 | 102 | 12 | 37142655 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ABCA4 RFTN2 GRIN2A KIF24 GRSF1 RCOR2 OAF PIK3R2 PRAMEF14 RNASEH2C TP53RK | 1.06e-03 | 1242 | 102 | 11 | 30973865 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.23e-03 | 552 | 102 | 7 | 10737800 | |
| Pubmed | 1.26e-03 | 18 | 102 | 2 | 34455539 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.26e-03 | 18 | 102 | 2 | 12119179 | |
| Interaction | PCDHA10 interactions | 8.93e-12 | 22 | 99 | 7 | int:PCDHA10 | |
| Interaction | PCDHA8 interactions | 2.88e-07 | 55 | 99 | 6 | int:PCDHA8 | |
| Interaction | PCDHA3 interactions | 6.42e-07 | 34 | 99 | 5 | int:PCDHA3 | |
| Interaction | PCDHA11 interactions | 2.01e-06 | 19 | 99 | 4 | int:PCDHA11 | |
| Interaction | PCDHA6 interactions | 9.45e-06 | 9 | 99 | 3 | int:PCDHA6 | |
| Interaction | PCDHA1 interactions | 9.45e-06 | 9 | 99 | 3 | int:PCDHA1 | |
| Interaction | LONP2 interactions | 1.34e-05 | 62 | 99 | 5 | int:LONP2 | |
| Interaction | ABCB9 interactions | 2.27e-05 | 34 | 99 | 4 | int:ABCB9 | |
| Interaction | FLT3 interactions | PCDHA9 PCDHA13 PCDHA12 RNF213 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 | 2.70e-05 | 318 | 99 | 9 | int:FLT3 |
| Interaction | PCDHA7 interactions | 4.02e-05 | 14 | 99 | 3 | int:PCDHA7 | |
| Interaction | FOXD4L6 interactions | 9.80e-05 | 49 | 99 | 4 | int:FOXD4L6 | |
| Interaction | PCDHGA10 interactions | 1.05e-04 | 19 | 99 | 3 | int:PCDHGA10 | |
| Cytoband | 5q31 | 2.18e-10 | 115 | 102 | 8 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 3.71e-07 | 298 | 102 | 8 | chr5q31 | |
| Cytoband | 15q21 | 2.65e-04 | 11 | 102 | 2 | 15q21 | |
| Cytoband | 11q13.1 | 3.84e-04 | 63 | 102 | 3 | 11q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.07e-04 | 172 | 102 | 4 | chr16p12 | |
| Cytoband | 12q14.3 | 9.05e-04 | 20 | 102 | 2 | 12q14.3 | |
| Cytoband | 7p22.3 | 2.62e-03 | 34 | 102 | 2 | 7p22.3 | |
| GeneFamily | Clustered protocadherins | 3.03e-10 | 64 | 78 | 8 | 20 | |
| GeneFamily | ATP binding cassette subfamily A | 3.10e-07 | 14 | 78 | 4 | 805 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.80e-04 | 7 | 78 | 2 | 1113 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 7.90e-06 | 261 | 101 | 8 | MM1277 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-08 | 197 | 102 | 8 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 3.03e-07 | 192 | 102 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-07 | 193 | 102 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 184 | 102 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 184 | 102 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 184 | 102 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.74e-06 | 188 | 102 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.04e-06 | 190 | 102 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.04e-06 | 190 | 102 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.51e-06 | 193 | 102 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.68e-06 | 194 | 102 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.68e-06 | 194 | 102 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 195 | 102 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 195 | 102 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.02e-06 | 196 | 102 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-06 | 113 | 102 | 5 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-06 | 113 | 102 | 5 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-06 | 113 | 102 | 5 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-06 | 199 | 102 | 6 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-06 | 200 | 102 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 127 | 102 | 5 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.89e-05 | 155 | 102 | 5 | 57259549d7ad97d9f628b821417be5ddac7dbff7 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 165 | 102 | 5 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.02e-05 | 166 | 102 | 5 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 170 | 102 | 5 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 170 | 102 | 5 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 170 | 102 | 5 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.02e-05 | 174 | 102 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 174 | 102 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.02e-05 | 174 | 102 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 177 | 102 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 178 | 102 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | NS-critical-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.75e-05 | 179 | 102 | 5 | 6153e7a0eeae83e7d88f1a20093bf2113e8d66b1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.90e-05 | 180 | 102 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-05 | 181 | 102 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 182 | 102 | 5 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 182 | 102 | 5 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 182 | 102 | 5 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.38e-05 | 183 | 102 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 184 | 102 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 184 | 102 | 5 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.55e-05 | 184 | 102 | 5 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 185 | 102 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 185 | 102 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-05 | 186 | 102 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.07e-05 | 187 | 102 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.25e-05 | 188 | 102 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 188 | 102 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.25e-05 | 188 | 102 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.00e-05 | 192 | 102 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.00e-05 | 192 | 102 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.20e-05 | 193 | 102 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.20e-05 | 193 | 102 | 5 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.20e-05 | 193 | 102 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.40e-05 | 194 | 102 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 194 | 102 | 5 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.40e-05 | 194 | 102 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 194 | 102 | 5 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.61e-05 | 195 | 102 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.61e-05 | 195 | 102 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-05 | 195 | 102 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.82e-05 | 196 | 102 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.82e-05 | 196 | 102 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.82e-05 | 196 | 102 | 5 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.03e-05 | 197 | 102 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.03e-05 | 197 | 102 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 9.03e-05 | 197 | 102 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 198 | 102 | 5 | 8de1808898e63cd74b131baeb9610e88363a41d1 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.25e-05 | 198 | 102 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.47e-05 | 199 | 102 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.47e-05 | 199 | 102 | 5 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 200 | 102 | 5 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 200 | 102 | 5 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 200 | 102 | 5 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | control-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 125 | 102 | 4 | 30f593fadbe850cedd622711005f9069ad57cc03 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 125 | 102 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 128 | 102 | 4 | 003e133469899a9abe3a7f6d7f580583b281f412 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 129 | 102 | 4 | a60935ff9c5a841899ccfe90531533ba4c546df3 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.27e-04 | 143 | 102 | 4 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-04 | 143 | 102 | 4 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 144 | 102 | 4 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-04 | 151 | 102 | 4 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 4.32e-04 | 154 | 102 | 4 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 4.54e-04 | 156 | 102 | 4 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 156 | 102 | 4 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 156 | 102 | 4 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.54e-04 | 156 | 102 | 4 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.98e-06 | 197 | 102 | 8 | 2212_DN | |
| Disease | 1,5 anhydroglucitol measurement | 5.74e-14 | 29 | 101 | 8 | EFO_0008009 | |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 SNX29 | 1.84e-11 | 87 | 101 | 9 | EFO_0004340, EFO_0004765 |
| Disease | Abnormality of refraction | SMG1 PCDHA9 ABCA4 BCAS3 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 GRIN2A DHX15 | 5.22e-07 | 673 | 101 | 13 | HP_0000539 |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 APC PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 GRIN2A LRP1B SNX29 | 5.59e-07 | 566 | 101 | 12 | EFO_0007660, EFO_0008354 |
| Disease | neutrophil count, basophil count | 1.07e-06 | 224 | 101 | 8 | EFO_0004833, EFO_0005090 | |
| Disease | post-traumatic stress disorder | 6.34e-06 | 202 | 101 | 7 | EFO_0001358 | |
| Disease | post-traumatic stress disorder symptom measurement | 9.41e-06 | 82 | 101 | 5 | EFO_0008535 | |
| Disease | pulse pressure measurement | USP34 BNC2 PCDHA9 ZNF423 PCDHA13 PCDHA12 RNF213 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 ZNF831 RCOR2 DHX15 ADAMTS15 | 2.00e-05 | 1392 | 101 | 16 | EFO_0005763 |
| Disease | vital capacity | USP34 BNC2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 GRIN2A ADAMTS15 ATP2A2 LTBP4 | 8.13e-05 | 1236 | 101 | 14 | EFO_0004312 |
| Disease | systemic mastocytosis | 8.48e-05 | 25 | 101 | 3 | MONDO_0016586 | |
| Disease | Hypoplastic Left Heart Syndrome | 1.15e-04 | 5 | 101 | 2 | C0152101 | |
| Disease | Muscular Dystrophy, Duchenne | 1.72e-04 | 6 | 101 | 2 | C0013264 | |
| Disease | Moyamoya disease | 3.51e-04 | 40 | 101 | 3 | MONDO_0016820 | |
| Disease | Colorectal Neoplasms | 3.90e-04 | 277 | 101 | 6 | C0009404 | |
| Disease | Calcium channel blocker use measurement | 8.45e-04 | 213 | 101 | 5 | EFO_0009930 | |
| Disease | unipolar depression | BNC2 ABCA13 RNF213 PCDHA6 PCDHA5 PCDHA3 PCDHA1 SNX29 TRIM10 LINC-PINT DMD ATP2A2 | 8.59e-04 | 1206 | 101 | 12 | EFO_0003761 |
| Disease | gallbladder cancer (is_implicated_in) | 8.83e-04 | 13 | 101 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | urate measurement | 1.00e-03 | 895 | 101 | 10 | EFO_0004531 | |
| Disease | BMI-adjusted leptin measurement | 1.18e-03 | 15 | 101 | 2 | EFO_0007793 | |
| Disease | Infiltrating duct carcinoma of female breast | 2.33e-03 | 21 | 101 | 2 | C3165106 | |
| Disease | neutrophil count | BNC2 PCDHA9 ZNF423 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 EPS15L1 LINC-PINT | 2.70e-03 | 1382 | 101 | 12 | EFO_0004833 |
| Disease | leptin measurement | 2.74e-03 | 81 | 101 | 3 | EFO_0005000 | |
| Disease | high density lipoprotein particle size measurement | 2.81e-03 | 170 | 101 | 4 | EFO_0008592 | |
| Disease | Colorectal Carcinoma | 2.86e-03 | 702 | 101 | 8 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HMDSKVDDHLIRGTE | 16 | Q8WU43 | |
| HGHSSVEDATTAMEL | 251 | Q8WTP8 | |
| DGHLDRDEFAVAMHL | 176 | Q9UBC2 | |
| AHRTDNKVHMGDLDV | 251 | Q9NUB1 | |
| RHMTLEGEEENGEVH | 216 | P41214 | |
| RHKEEEEFMAAGHAL | 786 | P0C7U0 | |
| HEHEELSLSVGDDMN | 116 | Q96M83 | |
| STHHMDEADLLGDRI | 1116 | P78363 | |
| ESMEGDEHIHSEVSE | 736 | Q6ZN30 | |
| DLHSHCRDSEGSMRE | 401 | Q969M2 | |
| GRTIILSTHHMDEAD | 1081 | O95477 | |
| LSTHHMDEADVLGDR | 1086 | O95477 | |
| GADMEEFHGRTLHDD | 61 | Q96SW2 | |
| SHDHVEDGMDVAVNL | 191 | Q86UQ4 | |
| THMVVVVDESSGDHA | 511 | P11532 | |
| LEAGADQEHKTDEMH | 421 | O75179 | |
| DEAKMRFAHIDGDHL | 611 | O43143 | |
| RHMSSMEHTEEGLRE | 846 | Q9H6U6 | |
| SHGDHSSMKLVEEAV | 276 | Q6ZW61 | |
| LEAVHGELVLDMEHG | 951 | Q2TAZ0 | |
| ADESMVKFHGADLEH | 226 | Q8TE58 | |
| QMREHSSLGHADLDA | 126 | O00170 | |
| SEEEHSHDSMIRVGT | 36 | Q8IZ40 | |
| HEDLQTDESSMDDRH | 481 | Q6VN20 | |
| RSLEEDMFDGLILHH | 66 | Q9HBI0 | |
| SLRAGMHSSVHLEEA | 811 | Q9Y5H5 | |
| MHSSVHLEEAGILRA | 816 | Q9Y5H5 | |
| ESMLHVRHGSDENCR | 181 | Q52LD8 | |
| AHAHVLKAMGLAEED | 241 | P48382 | |
| HFETHEDAVAAMLKD | 446 | Q12849 | |
| SLRAGMHSSVHLEEA | 811 | Q9UN73 | |
| MHSSVHLEEAGILRA | 816 | Q9UN73 | |
| DLHHAKDSEGIDIML | 286 | Q9H4G0 | |
| ALSEEHMEADGHAAV | 181 | Q96RG2 | |
| SLRAGMHSSVHLEEA | 811 | Q9Y5H6 | |
| MHSSVHLEEAGILRA | 816 | Q9Y5H6 | |
| SLRAGMHSSVHLEEA | 811 | Q9Y5H8 | |
| MHSSVHLEEAGILRA | 816 | Q9Y5H8 | |
| ERSSRKEEHGEAHMA | 156 | A1A4G5 | |
| VGDHSHIEEAAMDGT | 4046 | Q9NZR2 | |
| VDHVMDSVARKSEEH | 306 | Q8TAT5 | |
| NTHGSEDMDVISHLI | 396 | Q8N201 | |
| SAHKEGAMTVETHEA | 1181 | A6NM62 | |
| SAHSMHTVLDRIAGD | 371 | Q92485 | |
| ILAGDVETHAEMVHS | 66 | P40123 | |
| EISVDAMHVFIDEHG | 696 | A6NKB5 | |
| DHADHREGDRGSKMV | 1636 | P51805 | |
| REASLVSHDGHDIMK | 56 | A0A455ZAR2 | |
| DEVDDILLMDETHSH | 336 | Q16659 | |
| ISHSGSFRDSMEEVH | 1531 | Q8IVL0 | |
| SRETVLFSHEHMGSE | 1156 | Q5T7B8 | |
| AVSFMHEEAGVVHRD | 516 | O75676 | |
| REILSDMETHGAHTA | 266 | Q13219 | |
| ASLRAGMHSSVHLEE | 796 | Q9Y5H7 | |
| HEEGATRLARAMAEH | 1301 | Q8NDA8 | |
| SLRAGMHSSVHLEEA | 811 | Q9Y5I3 | |
| MHSSVHLEEAGILRA | 816 | Q9Y5I3 | |
| SLRAGMHSSVHLEEA | 811 | Q9Y5I0 | |
| MHSSVHLEEAGILRA | 816 | Q9Y5I0 | |
| ALMEDEDDLPHHEER | 606 | O00459 | |
| HDNPLRREEMHLEDS | 566 | P16615 | |
| RAEGLHQLEADHSRM | 166 | Q9BXL6 | |
| LSIDDDAHLRHDEIM | 741 | O43909 | |
| GRTILLSTHHMDEAD | 1171 | Q9BZC7 | |
| LSTHHMDEADLLGDR | 1176 | Q9BZC7 | |
| VEGHSAHIMELDSRD | 411 | Q5VV63 | |
| IHSARELGHEPSMQE | 271 | Q6V0L0 | |
| MFTTEGHIVSVDEHL | 576 | Q92611 | |
| LANHRDDEHGVASMV | 206 | Q8N2S1 | |
| DDEHGVASMVSVHVE | 211 | Q8N2S1 | |
| VSIIHHVTGEETEGM | 356 | Q9H583 | |
| HKSHLSSDEDEDMRD | 651 | Q9UJ99 | |
| SDLDNMASRDHDHLD | 416 | O00418 | |
| HVGDHILSIDGTSME | 296 | Q9Y3R0 | |
| DSPHHMRQDEESEFR | 176 | Q5T280 | |
| ASLRAGMHSSVHLEE | 801 | Q9UN75 | |
| HVEVDESRGMHICED | 46 | P49757 | |
| AEMHGELIEFNERLH | 596 | Q8TEQ0 | |
| ELHSEDTLQMDGHIL | 146 | Q9UIC8 | |
| RCHHSMSDNELEGRL | 241 | Q5SWL7 | |
| HMEREQVHKDESGTA | 1466 | Q5QGS0 | |
| LRNAAMGLEEETHAH | 2911 | Q96Q15 | |
| GELDENERDLMHIAH | 436 | Q9BYZ6 | |
| GSLAEADHTAHEEME | 216 | Q9NWH9 | |
| SGRDREDAVMHHLLC | 591 | Q14940 | |
| FHHRVSVSDDVGMDA | 476 | Q9UHV7 | |
| EVRFHMDSETHDPID | 636 | Q9Y2L1 | |
| AEEVRGLEHLHMDVA | 131 | Q86UD1 | |
| AERGHVLDSEDMGHS | 3016 | Q9NRC6 | |
| LSFDEEHRHAMNELG | 456 | P25054 | |
| GLEHRAEDGHEEAME | 3476 | Q63HN8 | |
| TSAGIMDHEEARRKH | 106 | P62244 | |
| MTDSEHAGHDREDGE | 1 | P61129 | |
| GQEDSEDMDSLLLHH | 561 | Q5TG30 | |
| DADLIMLGLTSHEAH | 206 | Q8IZH2 | |
| MESGDEAAIERHRVH | 1 | Q8TDP1 | |
| MANHLGVDVSRVADH | 421 | P48067 | |
| EERFTMGHSAHEETK | 116 | P02549 | |
| THLLSAAQGHMDEDV | 1386 | Q9BZF9 | |
| EHATHTMRFLEDAAA | 126 | Q9UDY6 | |
| ARMHDEDLIHGDLTT | 151 | Q96S44 | |
| IHMIDGDRDVHATKE | 1651 | Q01118 | |
| SAEDLESHMQVDHRD | 1131 | Q2M1K9 | |
| MLDACSHSEDPEHDI | 691 | Q70CQ2 | |
| HDGLHVASLADDKMV | 321 | Q9Y6I7 | |
| EAHLVQDMEGDSHRI | 1061 | Q5JPB2 | |
| AMHKRSAHGELEATE | 361 | P36508 | |
| TSTAEMEHGLHEART | 1371 | Q70EL1 | |
| RHGDDLKHTRSEMVE | 346 | Q7RTS7 | |
| MFHGTVTEELTSHEE | 1 | A6PVS8 | |
| IAVMLGHSHDVTERE | 36 | Q12879 |